Insider Transactions
| Date | Name | Title | Type | Shares Traded | Price Range |
|---|---|---|---|---|---|
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- |
| May 15, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Other acquisition or disposition | -- | -- |
| May 15, 2020 |
EVP, COO & CCO
|
EVP, COO & CCO | Other acquisition or disposition | -- | -- |
| May 15, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | $3.11 |
| May 14, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 350 | $3.06 |
| May 14, 2020 |
EVP, COO & CCO
|
EVP, COO & CCO | Open market or private sale of non-derivative or derivative security | 1,125 | $3.06 |
| May 13, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 400 | $3.25 |
| May 13, 2020 |
EVP, COO & CCO
|
EVP, COO & CCO | Open market or private sale of non-derivative or derivative security | 2,086 | $3.25 |
| Apr 23, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,500 | -- |
| Apr 23, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | -- |
| Apr 06, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Other acquisition or disposition | -- | -- |
| Apr 03, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Open market or private sale of non-derivative or derivative security | 854 | $2.18 |
| Apr 02, 2020 |
EVP & Chief Financial Officer
|
EVP & Chief Financial Officer | Other acquisition or disposition | -- | -- |
| Apr 02, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Open market or private sale of non-derivative or derivative security | 1,228 | $2.17 |
| Apr 02, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Other acquisition or disposition | -- | -- |
| Apr 02, 2020 |
EVP, COO & CCO
|
EVP, COO & CCO | Other acquisition or disposition | -- | -- |
| Apr 02, 2020 |
Director, CEO & President
|
Director, CEO & President | Other acquisition or disposition | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.